NO173992C - Analogifremgangsmaate til fremstilling av terapeutisk aktive benzocykloalkenyldihydroksyalkansyrederivater - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk aktive benzocykloalkenyldihydroksyalkansyrederivaterInfo
- Publication number
- NO173992C NO173992C NO900309A NO900309A NO173992C NO 173992 C NO173992 C NO 173992C NO 900309 A NO900309 A NO 900309A NO 900309 A NO900309 A NO 900309A NO 173992 C NO173992 C NO 173992C
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- different
- alkoxy
- radicals
- substitutents
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 4
- 229910052801 chlorine Inorganic materials 0.000 abstract 4
- 229910052731 fluorine Inorganic materials 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- 229940121375 antifungal agent Drugs 0.000 abstract 2
- 229910052794 bromium Inorganic materials 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 abstract 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- -1 C1-5-alkoxy Chemical group 0.000 abstract 1
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 abstract 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 125000000422 delta-lactone group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 102220067365 rs143592561 Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/235—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings
- C07C47/238—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/24—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
- C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8900790A FR2642065B1 (fr) | 1989-01-24 | 1989-01-24 | Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO900309D0 NO900309D0 (no) | 1990-01-23 |
| NO900309L NO900309L (no) | 1990-07-25 |
| NO173992B NO173992B (no) | 1993-11-22 |
| NO173992C true NO173992C (no) | 1994-03-02 |
Family
ID=9378002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO900309A NO173992C (no) | 1989-01-24 | 1990-01-23 | Analogifremgangsmaate til fremstilling av terapeutisk aktive benzocykloalkenyldihydroksyalkansyrederivater |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5082859A (de) |
| EP (1) | EP0380392B1 (de) |
| JP (1) | JP2561354B2 (de) |
| AR (1) | AR247206A1 (de) |
| AT (1) | ATE104666T1 (de) |
| AU (1) | AU629602B2 (de) |
| CA (1) | CA2008341C (de) |
| CZ (1) | CZ278567B6 (de) |
| DD (2) | DD291749A5 (de) |
| DE (1) | DE69008205T2 (de) |
| DK (1) | DK0380392T3 (de) |
| DZ (1) | DZ1390A1 (de) |
| ES (1) | ES2055350T3 (de) |
| FR (1) | FR2642065B1 (de) |
| GE (1) | GEP19971017B (de) |
| HU (1) | HU206307B (de) |
| IE (1) | IE64243B1 (de) |
| IL (1) | IL93124A (de) |
| MA (1) | MA21737A1 (de) |
| NO (1) | NO173992C (de) |
| NZ (1) | NZ232226A (de) |
| OA (1) | OA09190A (de) |
| PT (1) | PT92945B (de) |
| RU (1) | RU2012554C1 (de) |
| SK (1) | SK278578B6 (de) |
| TN (1) | TNSN90008A1 (de) |
| YU (1) | YU48227B (de) |
| ZA (1) | ZA90511B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2630111B1 (fr) * | 1988-04-13 | 1990-07-27 | Adir | Nouveaux derives trieniques de structure chromenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2630110B1 (fr) * | 1988-04-13 | 1990-07-27 | Adir | Nouveaux derives heteroarotinoides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US5504106A (en) * | 1992-06-25 | 1996-04-02 | G. D. Searle & Co. | Phenyl amidine alkanoic acids and lactones useful as platelet aggregation inhibitors |
| US6083497A (en) | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| WO1999032434A1 (en) * | 1997-12-19 | 1999-07-01 | Warner-Lambert Export Limited | Process for the synthesis of 1,3-diols |
| FR2772761B1 (fr) | 1997-12-23 | 2000-05-26 | Lipha | Nouveaux derives de n-phenylamide et n-pyridylamide, leur procede de preparation et compositions pharmaceutiques les contenant |
| WO2005007110A2 (en) * | 2003-07-11 | 2005-01-27 | Pro-Pharmaceuticals, Inc. | Compositions and methods for hydrophobic drug delivery |
| US20050053664A1 (en) * | 2003-09-08 | 2005-03-10 | Eliezer Zomer | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| EP1718146A2 (de) * | 2004-02-13 | 2006-11-08 | Pro-Pharmaceuticals, Inc. | Zusammensetzungen und verfahren zur behandlung von akne und candida |
| WO2006017417A2 (en) * | 2004-08-02 | 2006-02-16 | Pro-Pharmaceuticals, Inc. | Compositions and methods for the enhancement of chemotherapy with microbial cytotoxins |
| MX2007006279A (es) * | 2004-12-15 | 2007-06-14 | Solvay Pharm Gmbh | Composiciones farmaceuticas que comprenden inhibidores de nep, inhibidores del sistema de produccion de endotelina endogena, e inhibidores de hmg coa-reductasa. |
| US7776889B2 (en) * | 2005-03-31 | 2010-08-17 | Schering Corporation | Spirocyclic thrombin receptor antagonists |
| US20070048351A1 (en) * | 2005-09-01 | 2007-03-01 | Prescient Medical, Inc. | Drugs coated on a device to treat vulnerable plaque |
| ES2378281T3 (es) | 2006-07-05 | 2012-04-10 | Nycomed Gmbh | Combinación de atorvastatina con un inhibidor de fosfodiesterasa 4 para el tratamiento de neumopatías inflamatorias |
| CN101570510B (zh) * | 2008-04-30 | 2011-08-31 | 上海医药工业研究院 | 喹啉类化合物及其药物组合物、制备方法和应用 |
| AU2013214693B2 (en) | 2012-02-02 | 2017-02-23 | Kenneth Gek-Jin OOI | Improvements in tear film stability |
| MY160723A (en) * | 2013-12-30 | 2017-03-15 | Univ Putra Malaysia | An anticoagulant |
| US20200129440A1 (en) | 2017-01-23 | 2020-04-30 | Dong Wha Pharm. Co., Ltd. | Complex formulation comprising hmg-coa reductase inhibitor and clopidogrel |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3063585D1 (en) * | 1979-05-19 | 1983-07-07 | Beecham Group Plc | Chroman derivatives, processes for their preparation and pharmaceutical compositions containing them |
| US4556676A (en) * | 1979-11-01 | 1985-12-03 | Pfizer Inc. | Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| ATE60571T1 (de) * | 1984-12-04 | 1991-02-15 | Sandoz Ag | Inden-analoga von mevalonolakton und ihre derivate. |
| WO1987004430A2 (en) * | 1986-01-16 | 1987-07-30 | Schering Corporation | Fused benzazepines |
| JPS62181276A (ja) * | 1986-02-06 | 1987-08-08 | Sagami Chem Res Center | ２ｈ−クロメン誘導体 |
| GB8611837D0 (en) * | 1986-05-15 | 1986-06-25 | Plessey Co Plc | Photochromic spiropyran compounds |
| EP0298466A3 (de) * | 1987-07-10 | 1990-10-24 | F. Hoffmann-La Roche Ag | Substituierte Alkencarbonsäureamide und Derivate |
-
1989
- 1989-01-24 FR FR8900790A patent/FR2642065B1/fr not_active Expired - Lifetime
-
1990
- 1990-01-22 IL IL9312490A patent/IL93124A/en not_active IP Right Cessation
- 1990-01-22 DE DE69008205T patent/DE69008205T2/de not_active Expired - Fee Related
- 1990-01-22 ES ES90400161T patent/ES2055350T3/es not_active Expired - Lifetime
- 1990-01-22 DK DK90400161.7T patent/DK0380392T3/da active
- 1990-01-22 EP EP90400161A patent/EP0380392B1/de not_active Expired - Lifetime
- 1990-01-22 DZ DZ900008A patent/DZ1390A1/fr active
- 1990-01-22 AT AT9090400161T patent/ATE104666T1/de not_active IP Right Cessation
- 1990-01-23 MA MA21999A patent/MA21737A1/fr unknown
- 1990-01-23 DD DD90337274A patent/DD291749A5/de not_active IP Right Cessation
- 1990-01-23 NO NO900309A patent/NO173992C/no unknown
- 1990-01-23 HU HU90239A patent/HU206307B/hu not_active IP Right Cessation
- 1990-01-23 CA CA002008341A patent/CA2008341C/fr not_active Expired - Fee Related
- 1990-01-23 IE IE26090A patent/IE64243B1/en not_active IP Right Cessation
- 1990-01-23 OA OA59728A patent/OA09190A/xx unknown
- 1990-01-23 AR AR90315991A patent/AR247206A1/es active
- 1990-01-23 DD DD344416A patent/DD300422A5/de unknown
- 1990-01-23 RU SU904743212A patent/RU2012554C1/ru active
- 1990-01-24 AU AU48797/90A patent/AU629602B2/en not_active Ceased
- 1990-01-24 PT PT92945A patent/PT92945B/pt not_active IP Right Cessation
- 1990-01-24 CZ CS90341A patent/CZ278567B6/cs not_active IP Right Cessation
- 1990-01-24 YU YU12490A patent/YU48227B/sh unknown
- 1990-01-24 JP JP2012746A patent/JP2561354B2/ja not_active Expired - Lifetime
- 1990-01-24 TN TNTNSN90008A patent/TNSN90008A1/fr unknown
- 1990-01-24 NZ NZ232226A patent/NZ232226A/xx unknown
- 1990-01-24 US US07/469,121 patent/US5082859A/en not_active Expired - Fee Related
- 1990-01-24 ZA ZA90511A patent/ZA90511B/xx unknown
- 1990-01-24 SK SK341-90A patent/SK278578B6/sk unknown
-
1993
- 1993-03-30 GE GEAP1993645A patent/GEP19971017B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO173992C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive benzocykloalkenyldihydroksyalkansyrederivater | |
| DE69209290D1 (de) | Perhydroisoindolderivate, ihre herstellung und diese enthaltende arzneimittel | |
| YU17092A (sh) | Derivati 2,4-diaminohinazolina | |
| UA41272C2 (uk) | Естери тієнілкарбонової кислоти і аміноспиртів, їх продукти кватернізації і кислотно-адитивні солі та фармацевтична композиція | |
| MY128048A (en) | Phenyl- and aminophenyl- alkysulfonamide and urea derivatives. | |
| ES2130116T3 (es) | Derivados de piperazina. | |
| IL64905A (en) | Process for the preparation of 2-penems,carbapenems,carbacephams,oxapenems,and azapenems,some novel such compounds and pharmaceutical compositions containing them | |
| YU247190A (sh) | Heterociklični derivati, njihovo dobivanje i lekovi koji ih sadrže | |
| NO911158L (no) | Hydantoinderivater. | |
| KR900018006A (ko) | 인간 신경 성장인자의 촉진용 페놀 유도체 | |
| ATE157077T1 (de) | Substituierte phenoxy-isobuttersäuren und ihre ester | |
| MX9206245A (es) | Nuevas ftalazinas, que en la posicion 1 contienen una agrupacion eter o tioeter y el procedimiento para su elaboracion. | |
| DE3676763D1 (de) | Indolcarboxamidderivate, ihre salze, verfahren und zwischenprodukte, anwendung als heilmittel und zusammensetzungen die sie enthalten. | |
| NO171555C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive, substituerte alkanfenoner | |
| SE9301732D0 (sv) | New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins | |
| KR910007845A (ko) | 디사이클로헥실에틸렌 유도체 | |
| ATE197297T1 (de) | 3-oxo-1,4-benzothiazin-derivate | |
| DE69402058D1 (de) | Perhydroisoindol-derivate, deren herstellung und die sie behaltende pharmazeutische zusammenfassungen | |
| ATE206050T1 (de) | Okulares hypotensium | |
| ATE109485T1 (de) | Derivate von n-(vincristinyl-23) und n- (noranhydro-5-vinblastinyl-23) von amino-1- methylphosphonsäure, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| DE3867494D1 (de) | Fluor enthaltende vitamin-d2-derivate. | |
| ATE117682T1 (de) | Substituierte benzothiazolinone, ihre herstellung und sie enthaltende pharmazeutische zusammenstellungen. | |
| ATE183742T1 (de) | 2-aminopyrazin-5-carbonsäureamid derivate, deren herstellung und deren verwendung als heilmittel |